1.
Gobbi P, Ghirardelli M, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin’s lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Haematologica [Internet]. 2000Mar.1 [cited 2026Nov.17];85(3):263-8. Available from: https://haematologica.org/article/view/1617